Phase 3 Hepatitis C Trials
2 Phase 3 trials for Hepatitis C. Phase 3 trials are the final stage of testing before a treatment can be submitted for FDA approval.
What is a Phase 3 trial?
Phase 3 clinical trials study a treatment in large groups (hundreds to thousands of people) to confirm its effectiveness, monitor side effects, and compare it to standard treatments. These trials are the last major step before the FDA considers approving a new treatment.
RECRUITINGPhase 3NCT07037277
C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV
The purpose of this study is to compare the efficacy and safety of BEM/RZR to SOF/VEL in adults with chronic HCV.
Sponsor: Atea Pharmaceuticals, Inc.Enrolling: 88020 locations
RECRUITINGPhase 3NCT03770936
Effect of Some Drugs on Liver Fibrosis
Effect of Some Drugs on Liver Fibrosis
Sponsor: Sherief Abd-ElsalamEnrolling: 451 location